Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

CUSIP: 98422T100

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
73,644,024
Total 13F shares
18,775,939
Share change
-217,467
Total reported value
$132,746,000
Price per share
$7.07
Number of holders
41
Value change
-$2,569,332
Number of buys
10
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 98422T100?
CUSIP 98422T100 identifies XLO - Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO) as of Q1 2022

As of 31 Mar 2022, Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,775,939 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, Atlas Venture Life Science Advisors, LLC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., RiverVest Venture Management LLC, Rock Springs Capital Management LP, AJU IB Investment Co., Ltd., Soleus Capital Management, L.P., and Artal Group S.A.. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.